Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic

Date Published06/30/2020
Author NameEllen Bombela
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name AGC Biologics
Parent companyAsahi Glass Company (AGC) Bioscience
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):280
Year reshoring announced:2020
Capital investment ($):100
Country(ies) from which reshored:Japan
City reshored to:Boulder
State(s) reshored to:CO
If relevant, work nearshored to:-
Product(s) reshoredbiopharma
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Proximity to customers/market, Under-utilized capacity
Find Reshoring Articles